Antimicrobial drug use and methicillin-resistant Staphylococcus aureus, Aberdeen, 1996-2000.
about
Surveillance of antibiotic resistanceSeasonality of MRSA infectionsGuidance on the Selection of Appropriate Indicators for Quantification of Antimicrobial Usage in Humans and Animals.Molecular epidemiology and antimicrobial susceptibility of clinical Staphylococcus aureus from healthcare institutions in GhanaMethicillin-resistant Staphylococcus aureus in German intensive care units during 2000-2003: data from Project SARI (Surveillance of Antimicrobial Use and Antimicrobial Resistance in Intensive Care Units).Impact of national policies on the microbial aetiology of surgical site infections in acute NHS hospitals in England: analysis of trends between 2000 and 2013 using multi-centre prospective cohort data.Sequential introduction of single room isolation and hand hygiene campaign in the control of methicillin-resistant Staphylococcus aureus in intensive care unitThe use of the temporal scan statistic to detect methicillin-resistant Staphylococcus aureus clusters in a community hospitalAn observational prospective study of topical acidified nitrite for killing methicillin-resistant Staphylococcus aureus (MRSA) in contaminated wounds.Antimicrobial stewardship programs in health care systems.Surveillance and epidemiology of MRSA bacteraemia in the UK.Molecular epidemiology of methicillin-resistant and methicillin-susceptible Staphylococcus aureus isolated from the eyeUsing interrupted time series analysis to assess associations of fluoroquinolone formulary changes with susceptibility of gram-negative pathogens and isolation rates of methicillin-resistant Staphylococcus aureusFeasibility and impact of an intensified antibiotic stewardship programme targeting cephalosporin and fluoroquinolone use in a tertiary care university medical center.HIC@RE … and its relevance for a company like RIEMSERSeasonal variations in Clostridium difficile infections are associated with influenza and respiratory syncytial virus activity independently of antibiotic prescriptions: a time series analysis in Quebec, Canada.Pseudomonas aeruginosa, Staphylococcus aureus, and fluoroquinolone use.Trends in Staphylococcus aureus bacteraemia and impacts of infection control practices including universal MRSA admission screening in a hospital in Scotland, 2006-2010: retrospective cohort study and time-series intervention analysis.Molecular and epidemiological evidence for spread of multiresistant methicillin-susceptible Staphylococcus aureus strains in hospitalsControl of methicillin-resistant Staphylococcus aureus in the UK.Puerperal sepsis in a rural hospital in Sudan.Epidemiology, clinical manifestations, and treatment options for skin and soft tissue infection caused by community-acquired methicillin-resistant Staphylococcus aureusThe importance and future of antimicrobial surveillance studies.Impact of an antimicrobial utilization program on antimicrobial use at a large teaching hospital: a randomized controlled trial.Proposed changes to management of lower respiratory tract infections in response to the Clostridium difficile epidemic.Resistant pathogen-associated skin and skin-structure infections: antibiotic options.Methicillin-resistant Staphylococcus aureus: the European landscape.Emergence and spread of antibiotic resistance following exposure to antibiotics.Resistance Elasticity of Antibiotic Demand in Intensive Care.Use of antibacterial prophylaxis for patients with neutropenia. Australian Consensus Guidelines 2011 Steering Committee.Superiority of D-zone Testing Method over Standard Method to detect Rnducible Resistance in Gram Positive Bacteria: a Prospective Surveillance from a Teaching Hospital in Saudi Arabia.Methicillin-resistant Staphylococcus aureus in Northeastern Scotland in 2003 to 2007: evolving strain distribution and resistance patterns.Assessing potential human health hazards and benefits from subtherapeutic antibiotics in the United States: tetracyclines as a case study.Perils of quinolone exposure in cancer patients: breakthrough bacteremia with multidrug-resistant organisms.Decline of EMRSA-16 amongst methicillin-resistant Staphylococcus aureus causing bacteraemias in the UK between 2001 and 2007.Antimicrobial susceptibility of Staphylococcus aureus isolated from children with impetigo in China from 2003 to 2007 shows community-associated methicillin-resistant Staphylococcus aureus to be uncommon and heterogeneous.Measuring the externality of antibacterial use from promoting antimicrobial resistance.Health-related quality of life after intensive care unit discharge: A comparison between 2 standard antibiotic regimens.The impact of pricing and patent expiration on demand for pharmaceuticals: an examination of the use of broad-spectrum antimicrobials.Antibiotic resistance in hospitals: a ward-specific random effect model in a low antibiotic consumption environment.
P2860
Q28082571-E6B2A48B-EDB1-4066-AE93-08AF1F811838Q28741596-36FC5356-8CD4-4271-8BB1-EEFA71FFDC92Q30245660-30EC2C44-A009-467D-94DE-5F1E98057950Q30359688-450A2041-82E7-46D7-802D-F4640EC669EAQ31032012-73659761-2E6F-4F66-92E2-607CC62A0BEDQ31151607-140CCCFF-FFA4-4C52-AE0B-924E950FBA52Q33686408-F607DEA3-90AA-4E66-AB82-08E2BF36D7F9Q33897903-F9BF8593-1543-4E8E-8340-F5FA9250C5E9Q34059800-417709C4-95CB-4F23-8764-47AA4462182BQ34097674-427BBA74-1407-4701-9870-E62A76198E10Q34437381-318624AC-7110-49D7-839F-CA42502AE4BCQ34495908-73F6E8B7-BCAC-410A-8F30-9465A7AFECD7Q34680578-91C2BDE1-7E26-4DDD-9612-75BDBF7F1C52Q35147331-94EA268E-33C5-4A27-8343-6902E41646EBQ35656823-9635ECE8-2207-43DD-9E72-E77B7E20D8DFQ35689261-C84BDC3A-F2D4-4B6B-8827-8A4966855EBCQ35873418-B01CF910-E1ED-4784-8992-E7226D6CDB60Q36045103-82E4E176-9EA3-4C62-AE7E-BD599FCE8272Q36313176-5CB39905-2B1A-48E1-BC06-2918514B13ABQ36332430-AFADFC4F-A40D-40F1-81A8-4448EEB26CB8Q36787266-12A564BC-8767-453D-AACB-18549721C6AAQ37083679-7C6DECFE-D643-4864-A237-08FFF0C12980Q37247114-AB5B5E5D-6A61-4C66-946C-6E48E30A6604Q37426706-ACC54892-87C6-43B5-BB46-8ACC68ADACCDQ37697321-47C7662E-4950-4942-B3C8-A1A7B0D53735Q37785546-43E67A06-F076-4604-A40E-E2D286DDC33AQ37869257-998967C2-E69F-4B72-8F17-5AB8F0E02629Q37896674-C6E64475-6A06-49FD-AF1D-CD6FFB08E1CEQ39708430-4A373894-264C-446D-828D-F4D73871DEADQ40335974-813BD390-C3E2-4358-ADD1-68A66A5F250CQ41949594-7543679B-ED4F-4B5E-A361-94D7A62092EFQ42772843-C5DF279D-E82E-40E8-85CE-B09C7974D23DQ43171463-1D25566B-6AB9-48BE-98BE-9A9B71383E42Q43201542-0083844A-5803-4126-9EB1-C7FF69D3FAE9Q43207777-85AEE4C2-8733-405F-AB11-664034EAE483Q43276481-74A63168-6011-41D9-BD9B-D452D9F5174AQ43630702-E5C0A554-417A-4342-8982-4CEC9CF793ADQ44244644-D2471F6D-1B3C-4828-856C-8A07D524BDC9Q44326553-BE548677-95C4-4C51-97FB-5AD0A2155A91Q44440432-9037634D-46B7-4E2B-8B97-2E0E352CD978
P2860
Antimicrobial drug use and methicillin-resistant Staphylococcus aureus, Aberdeen, 1996-2000.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Antimicrobial drug use and met ...... s aureus, Aberdeen, 1996-2000.
@ast
Antimicrobial drug use and met ...... s aureus, Aberdeen, 1996-2000.
@en
type
label
Antimicrobial drug use and met ...... s aureus, Aberdeen, 1996-2000.
@ast
Antimicrobial drug use and met ...... s aureus, Aberdeen, 1996-2000.
@en
prefLabel
Antimicrobial drug use and met ...... s aureus, Aberdeen, 1996-2000.
@ast
Antimicrobial drug use and met ...... s aureus, Aberdeen, 1996-2000.
@en
P2093
P2860
P356
P1476
Antimicrobial drug use and met ...... s aureus, Aberdeen, 1996-2000.
@en
P2093
Arielle Beyaert
David Stuart
Dominique L Monnet
Fiona M MacKenzie
Ian M Gould
José Maria López-Lozano
Máximo Camacho
Rachel Wilson
P2860
P304
P356
10.3201/EID1008.020694
P577
2004-08-01T00:00:00Z